However, chronic inflammation in general and inflammation in the tumor microenvironment in particular, caused by NF-κB upregulation over a long time range, increases aggressiveness, invasivenes [38,39], and correlates with poor prognosis in breast-cancer patients [40]. Here, NFKB1 is linked to breast carcinoma.